PPT1 Gene - Palmitoyl-Protein Thioesterase 1

PPT1 Gene

Introduction

Ppt1 Gene Palmitoyl Protein Thioesterase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

{{- <!-- PPT1 Gene Page - Palmitoyl-Protein Thioesterase 1 --> -}} [@trondle2022]

<div class="infobox infobox-gene"> [@hofmann2002]

| Attribute | Value | [@lyly2009]
|-----------|-------|
| Gene Symbol | PPT1 |
| Gene Name | Palmitoyl-Protein Thioesterase 1 |
| Official Full Name | Palmitoyl-Protein Thioesterase 1 |
| Chromosomal Location | 1p34.2 |
| GRCh38 Coordinates | chr1:40,285,938-40,313,917 |
| NCBI Gene ID | 5538 |
| OMIM ID | 256730 |
| Ensembl ID | ENSG00000131238 |
| UniProt ID | P60617 |
| Gene Family | Palmitoyl-protein thioesterase family |

</div>}

Overview

PPT1 Gene

Introduction

Ppt1 Gene Palmitoyl Protein Thioesterase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

{{- <!-- PPT1 Gene Page - Palmitoyl-Protein Thioesterase 1 --> -}} [@trondle2022]

<div class="infobox infobox-gene"> [@hofmann2002]

| Attribute | Value | [@lyly2009]
|-----------|-------|
| Gene Symbol | PPT1 |
| Gene Name | Palmitoyl-Protein Thioesterase 1 |
| Official Full Name | Palmitoyl-Protein Thioesterase 1 |
| Chromosomal Location | 1p34.2 |
| GRCh38 Coordinates | chr1:40,285,938-40,313,917 |
| NCBI Gene ID | 5538 |
| OMIM ID | 256730 |
| Ensembl ID | ENSG00000131238 |
| UniProt ID | P60617 |
| Gene Family | Palmitoyl-protein thioesterase family |

</div>}

Overview

The PPT1 gene encodes palmitoyl-protein thioesterase 1 (PPT1), a lysosomal enzyme that catalyzes the removal of palmitate (C16:0) fatty acid chains from cysteine residues of proteins. This post-translational modification (S-acylation/palmitoylation) regulates protein localization and function. Mutations in PPT1 cause Infantile Neuronal Ceroid Lipofuscinosis (INCL), the most severe form of Batten disease^[1].

Function

Enzymatic Activity

PPT1 is a 306-amino acid enzyme (34 kDa) that functions as a homodimer in the lysosome. It catalyzes:

Palmitoyl-protein + H₂O → Protein + Palmitate

This reaction removes lipid modifications from proteins, allowing their degradation in the lysosome^[1].

Normal Physiological Roles

• Protein Depalmitoylation: Removes palmitate from signaling proteins
• Lysosomal Protein Degradation: Essential for turnover of palmitoylated proteins
• Synaptic Function: Regulates synaptic vesicle proteins
• Neuronal Development: Critical for normal brain development
• Lipid Metabolism: Processes lipid-modified proteins

Molecular Interactions

PPT1 interacts with:

• Synaptic proteins (CSP, SNAP-25) - Palmitoylated substrates
• HSP70 - Chaperone function
• Lysosomal cathepsins - Degradation pathway
• Ras proteins - Depalmitoylation targets

Disease Associations

Infantile Neuronal Ceroid Lipofuscinosis (INCL)

PPT1 mutations cause the most severe form of NCL, characterized by^[1]:

| Feature | Onset | Progression |
|---------|-------|-------------|
| Developmental arrest | 6-12 months | Rapid decline |
| Vision loss | 12-18 months | Blindness by 2 years |
| Seizures | 12-18 months | Progressive myoclonic |
| Hypotonia | 6-12 months | Severe motor impairment |
| Microcephaly | 1-2 years | Progressive |
| Death | 3-10 years | Respiratory failure |

Common Mutations

| Mutation | Type | Frequency | Effect |
|----------|------|-----------|--------|
| p.R122X | Nonsense | 25% | Truncated enzyme |
| p.T75P | Missense | 15% | No activity |
| p.D208V | Missense | 10% | Severely reduced |
| p.L218P | Missense | 8% | No activity |
| p.W404X | Nonsense | 5% | Truncated |

Genotype-Phenotype Correlations

• Null/Null: Classic INCL, most severe
• Missense/Missense: Variable, often milder
• Residual activity: Later onset possible

Expression Patterns

• Tissue Distribution: Highest in brain (cerebellum, cortex), retina
• Brain Regions: Expressed in [neurons](/entities/neurons) and glia
• Cellular Localization: Lysosomal lumen
• Developmental Expression: High during fetal development and early infancy
• Transcript: 1.9 kb mRNA, 9 exons

Therapeutic Approaches

Current Treatments

• Anticonvulsants: For seizure management
• Supportive care: Feeding, positioning, physical therapy
• Respiratory support: As needed for complications

Experimental Therapies

• Enzyme replacement therapy: PPT1 enzyme delivered to lysosomes^[2]
• Gene therapy: AAV-vector CNS delivery in trials
• Stem cell therapy: Investigational approaches
• Substrate reduction therapy: Reducing accumulation

Clinical Trials

Several clinical trials are investigating gene therapy and enzyme replacement approaches for INCL.

Research Directions

Background

The study of Ppt1 Gene Palmitoyl Protein Thioesterase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Neuronal Ceroid Lipofuscinosis](/diseases/neuronal-ceroid-lipofuscinosis)
• [Batten Disease](/diseases/batten-disease)
• Infantile NCL
• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)

Pathway Diagram

The following diagram shows the key molecular relationships involving PPT1 Gene - Palmitoyl-Protein Thioesterase 1 discovered through SciDEX knowledge graph analysis: